Secondary Hypogonadism: Clinical Trials

3 trials for Secondary Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Secondary Hypogonadism: new trials by email Literature Review of Secondary Hypogonadism trials Research Report on Secondary Hypogonadism

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration
Androxal - Secondary Hypogonadism
Phase 1CompletedRepros Therapeutics Inc.62014-12-012015-03-12
Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function
Androxal 25 mg - Secondary Hypogonadism
Phase 1CompletedRepros Therapeutics Inc.192013-08-012014-01-24
Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function
Androxal 25 mg - Secondary Hypogonadism
Phase 1CompletedRepros Therapeutics Inc.262013-08-012014-08-11

Narrower conditions

Hypogonadism (3)

Broader conditions

Endocrine System Diseases (3)  ·  Gonadal Disorders (3)

Interventions

Enclomiphene (3)

Sponsors

Repros Therapeutics Inc. (3)

Countries

United States (3)

Top investigators

Barbara Cook, MD (1)